Comparison of the anti-inflammatory effects of fluorometholone 0.1% combined with levofloxacin 0.5% and tobramycin/dexamethasone eye drops after cataract surgery

被引:4
作者
Pei-Qing Chen [1 ]
Xue-Mei Han [2 ]
Ya-Nan Zhu [1 ]
Jia Xu [1 ]
机构
[1] Eye Center,the Second Affiliated Hospital of Zhejiang University School of Medicine
[2] Zhejiang Hospital of Traditional Chinese Medicine
关键词
fluorometholone; levofloxacin; tobramycin/; dexamethasone; phacoemulsification; inflammation;
D O I
暂无
中图分类号
R779.6 [眼外科手术学];
学科分类号
100212 ;
摘要
·AIM: To compare the combination of fluorometholone0.1% and levofloxacin 0.5% to tobramycin/dexamethasone eye drops in controlling inflammation and preventing infection after phacoemulsification with an intraocular lens implantation.·METHODS: Sixty eyes from 60 patients undergoing cataract phacoemulsification were randomized into two groups; half of the patients were treated with fluorometholone(6 times/d) combined with levofloxacin(4 times/d), while the other half were treated with tobramycin/dexamethasone(4 times/d) eye drops for one week. Preoperative and postoperative intraocular pressure, aqueous flare, corneal thickness, and signs and symptoms were recorded before the operation and1 wk following treatments.· RESULTS: There were no statistically significant differences between the two groups in corneal thickness(P ≥0.629), aqueous flare(P ≥0.398), and signs and symptoms scores(P ≥0.350) at each time point. Ocular hypertension was only observed in two eyes in the tobramycin/dexamethasone group.· CONCLUSION: Fluorometholone combined with levofloxacin treatment shows comparable efficacy but without the tendency to increase intraocular pressure;thus, it might be a better regimen for postoperative use.
引用
收藏
页码:1619 / 1623
页数:5
相关论文
共 10 条
  • [1] Prevention and Control of Perioperative Incision Infection in Patients Undergoing Day Cataract Surgery[J]. Chunyan Yang,Aihuan Chen,Yinghuan Wang,Xiaoqun Fang,Ronghua Ye,Jingyi Lin.Eye Science. 2014(03)
  • [2] A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients[J] . J. Stuart Elborn,David E. Geller,Douglas Conrad,Shawn D. Aaron,Alan R. Smyth,Rainald Fischer,Eitan Kerem,Scott C. Bell,Jeffery S. Loutit,Michael N. Dudley,Elizabeth E. Morgan,Donald R. VanDevanter,Patrick A. Flume.Journal of Cystic Fibrosis . 2015 (4)
  • [3] Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification[J] . Sabin Sahu,Jagat Ram,Reema Bansal,Surinder S. Pandav,Amod Gupta.Journal of Cataract & Refractive Surgery . 2015
  • [4] Bromfenac Sodium 0.1%, Fluorometholone 0.1% and Dexamethasone 0.1% for Control of Ocular Inflammation and Prevention of Cystoid Macular Edema after Phacoemulsification[J] . Wang,Qi-wei,Yao,Ke,Xu,Wen,Chen,Pei-qing,Shentu,Xing-chao,Xie,Xin,Weng,Yan,Zhang,Li,Jin,Chong-fei,Wu,Wei,Zhu,Ya-nan,Yu,Yin-hui.Ophthalmologica . 2013 (4)
  • [5] Ketorolac plus Tobramycin/Dexamethasone versus Tobramycin/Dexamethasone after Uneventful Phacoemulsification Surgery: A Randomized Controlled Trial[J] . Chatziralli,Irini P,Papazisis,Leonidas,Sergentanis,Theodoros N.Ophthalmologica . 2011 (2)
  • [6] A rabbit model of age‐dependant ocular hypertensive response to topical corticosteroids[J] . Yi Qin,Shi Lam,Gary Hin Fai Yam,Kwong Wai Choy,David Tai Li Liu,Thomas Yee Hang Chiu,Wai Ying Li,Dennis Shun Chiu Lam,Chi Pui Pang,Dorothy Shu Ping Fan.Acta Ophthalmologica . 2010 (6)
  • [7] The Effects of Dexamethasone on the Na,K-ATPase Activity and Pump Function of Corneal Endothelial Cells[J] . Shin Hatou,Masakazu Yamada,Hiroshi Mochizuki,Atsushi Shiraishi,Takeshi Joko,Teruo Nishida.Current Eye Research . 2009 (5)
  • [8] Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution[J] . Hyung Cho,Kenneth Wolf,Eric Wolf.Clinical Ophthalmology . 2008 (defa)
  • [9] Comparison of topical 0.7% dexamethasone–cyclodextrin with 0.1% dexamethasone sodium phosphate for postcataract inflammation[J] . K. Matti Saari,Laura Nelimarkka,Virpi Ahola,Thorsteinn Loftsson,Einar Stefánsson.Graefe’s Archive for Clinical and Experimental Ophthalmology . 2006 (5)
  • [10] Control of intra-ocular inflammation associated with cataract surgery
    El-Harazi, Sherif M.
    Feldman, Robert M.
    [J]. CURRENT OPINION IN OPHTHALMOLOGY, 2001, 12 (01) : 4 - 8